Don't Miss: Best Chance to Access Midcap Stocks Research at 80% OFF
Here is the latest financial fact sheet of CHANDRA BHAGAT PHARMA. For more details, see the CHANDRA BHAGAT PHARMA quarterly results and CHANDRA BHAGAT PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -11.1 |
No. of shares | m | 7.55 |
1 Week | % | -7.1 |
1 Month | % | 2.0 |
1 Year | % | -7.3 |
52 week H/L | Rs | 160.0/80.0 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
CHANDRA BHAGAT PHARMA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | NA | 52 | 58 | 149 | 136 | |
Low | Rs | NA | 38 | 31 | 40 | 83 | |
Sales per share (Unadj.) | Rs | 1,586.2 | 124.5 | 93.6 | 124.6 | 158.5 | |
Earnings per share (Unadj.) | Rs | 10.3 | 0.4 | 0.3 | 1.1 | 1.2 | |
Diluted earnings per share | Rs | 0.9 | 0.4 | 0.3 | 1.1 | 1.2 | |
Cash flow per share (Unadj.) | Rs | 11.0 | 0.5 | 0.4 | 1.1 | 1.3 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 215.6 | 34.0 | 34.3 | 35.3 | 36.4 | |
Adj. book value per share | Rs | 19.1 | 34.0 | 34.3 | 35.4 | 36.4 | |
Shares outstanding (eoy) | m | 0.67 | 7.55 | 7.55 | 7.55 | 7.55 | |
Price / Sales ratio | x | 0 | 0.4 | 0.5 | 0.8 | 0.7 | |
Avg P/E ratio | x | 0 | 108.0 | 175.7 | 89.2 | 91.2 | |
P/CF ratio (eoy) | x | 0 | 98.0 | 107.7 | 85.1 | 81.3 | |
Price / Book Value ratio | x | 0 | 1.3 | 1.3 | 2.7 | 3.0 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 0 | 340 | 334 | 710 | 826 | |
Total wages/salary | Rs m | 45 | 23 | 19 | 15 | 13 |
CHANDRA BHAGAT PHARMA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 1,063 | 940 | 707 | 941 | 1,197 | |
Other income | Rs m | 4 | 4 | 5 | 16 | 3 | |
Total revenues | Rs m | 1,067 | 944 | 712 | 957 | 1,200 | |
Gross profit | Rs m | 46 | 31 | 37 | 28 | 32 | |
Depreciation | Rs m | 1 | 0 | 1 | 0 | 1 | |
Interest | Rs m | 41 | 31 | 38 | 32 | 22 | |
Profit before tax | Rs m | 9 | 4 | 3 | 11 | 12 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 2 | 1 | 1 | 3 | 3 | |
Profit after tax | Rs m | 7 | 3 | 2 | 8 | 9 | |
Gross profit margin | % | 4.3 | 3.3 | 5.2 | 2.9 | 2.7 | |
Effective tax rate | % | 22.3 | 25.5 | 31.9 | 27.3 | 22.1 | |
Net profit margin | % | 0.6 | 0.3 | 0.3 | 0.8 | 0.8 |
CHANDRA BHAGAT PHARMA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 813 | 729 | 700 | 707 | 589 | |
Current liabilities | Rs m | 525 | 341 | 329 | 381 | 269 | |
Net working cap to sales | % | 27.1 | 41.3 | 52.5 | 34.7 | 26.7 | |
Current ratio | x | 1.5 | 2.1 | 2.1 | 1.9 | 2.2 | |
Inventory Days | Days | 14 | 3 | 0 | 1 | 0 | |
Debtors Days | Days | 90,317,028 | 54,487,830 | 796 | 582 | 250 | |
Net fixed assets | Rs m | 5 | 4 | 4 | 5 | 7 | |
Share capital | Rs m | 7 | 75 | 75 | 75 | 75 | |
"Free" reserves | Rs m | 138 | 181 | 183 | 191 | 199 | |
Net worth | Rs m | 144 | 257 | 259 | 267 | 275 | |
Long term debt | Rs m | 115 | 109 | 95 | 54 | 39 | |
Total assets | Rs m | 828 | 747 | 718 | 725 | 606 | |
Interest coverage | x | 1.2 | 1.1 | 1.1 | 1.3 | 1.5 | |
Debt to equity ratio | x | 0.8 | 0.4 | 0.4 | 0.2 | 0.1 | |
Sales to assets ratio | x | 1.3 | 1.3 | 1.0 | 1.3 | 2.0 | |
Return on assets | % | 5.8 | 4.6 | 5.5 | 5.6 | 5.1 | |
Return on equity | % | 4.8 | 1.2 | 0.7 | 3.0 | 3.3 | |
Return on capital | % | 19.2 | 9.7 | 11.4 | 13.5 | 10.7 | |
Exports to sales | % | 0 | 0 | 52.0 | 75.6 | 48.1 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 368 | 711 | 576 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 0 | 18 | 368 | 711 | 576 | |
Fx outflow | Rs m | 0 | 1 | 70 | 11 | 7 | |
Net fx | Rs m | 0 | 17 | 297 | 700 | 569 |
CHANDRA BHAGAT PHARMA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 41 | -74 | 83 | 124 | 53 | |
From Investments | Rs m | -4 | 1 | 1 | 1 | -1 | |
From Financial Activity | Rs m | -37 | 69 | -64 | -96 | -44 | |
Net Cashflow | Rs m | -1 | -4 | 20 | 29 | 8 |
Share Holding
Shareholding as on Sep 2023
|
Company Information
|
CHM: Hemant Chandravadan Bhagat | COMP SEC: Payal Bansal | YEAR OF INC: 2003 | BSE CODE: 542934 | FV (Rs): 10 | DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES SUN PHARMA CIPLA
Compare CHANDRA BHAGAT PHARMA With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES SUN PHARMA CIPLA
Asian share markets are mixed today after US shares extended their losing streak to the longest since January 2024.